Article
Proteomics, Personalized Medicine and Cancer
21 May 2021
Abstract excerpt
As of 2020 the human genome and proteome are both at >90% completion based on high stringency analyses. This has been largely achieved by major technological advances over the last 20 years and has enlarged our understanding of human health and disease, including cancer, and is supporting the current trend towards personalized/precision medicine. This is due to improved screening, novel therapeutic approaches and...
Topics
Join the communities discussing this publication.